For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).

SARASOTA, FL - Silo Pharma , Inc. (NASDAQ:SILO), a $6.91 million market cap biopharmaceutical company currently trading at $1.54 per share, has announced promising preliminary results from a study on ...

Hundreds of Texas convenience stores are selling untested, highly addictive and potentially deadly drugs as over-the-counter ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.